MEDNAX Inc (N:MD)

Business Focus: Healthcare Facilities & Services

Sector:  Healthcare Industry:  Healthcare Facilities & Services
 
See Regulatory Filings on SEC
Company Contact
Address: 1301 Concord Ter
SUNRISE FL 33323-2843
Tel: 1-954-3840175
Website: https://www.mednax.com
IR: See website
<
Key People
Cesar L. Alvarez
Independent Chairman of the Board
Roger J. Medel
Chief Executive Officer, Director
Stephen D. Farber
Chief Financial Officer, Executive Vice President
David A. Clark
Chief Operating Officer
John C. Pepia
Senior Vice President, Chief Accounting Officer
Dominic J. Andreano
Senior Vice President, General Counsel, Secretary
Kevin Smith
Interim Vice President - Advanced Practice Anesthesia
   
Business Overview
MEDNAX, Inc. is a provider of physician services, including newborn, anesthesia, maternal-fetal, teleradiology, pediatric cardiology and other pediatric subspecialty care. As of November 26, 2018, the Company's national network consisted of over 4,225 physicians in all 50 states and Puerto Rico, primarily within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications. As of December 31, 2016, the Company had over 1,390 affiliated physicians providing anesthesia care to patients in connection with surgical and other procedures, as well as pain management. As of December 31, 2016, the Company had 270 affiliated physicians providing maternal-fetal and obstetrical medical care to expectant mothers experiencing complicated pregnancies primarily in areas where its affiliated neonatal physicians practice.
Financial Overview
For the six months ended 30 June 2019, MEDNAX Inc revenues remained flat at $1.72B. Net income before extraordinary items decreased 43% to $77.2M. Revenues reflect market conditions. Net income was partially offset by Practice salaries and benefits increase of 3% to $1.23B (expense), Transformational and restructuring relat increase from $0K to $31M (expense), Interest expense increase of 49% to $61.8M (expense).
Employees: 7,625 as of Dec 31, 2018
Reporting Currency: U.S. Dollars
Enterprise value: $3,812M as of Jun 30, 2019
Annual revenue (TTM): $3,549M as of Jun 30, 2019
EBITDA (TTM): $501.16M as of Jun 30, 2019
Net annual income (TTM): $202.96M as of Jun 30, 2019
Free cash flow (TTM): $284.72M as of Jun 30, 2019
Net Debt Last Fiscal Year: $1,973M as of Jun 30, 2019
Shares outstanding: 87,868,988 as of Aug 2, 2019
Index Membership: S&P 400 Mid Cap
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization